A phase I, double-blind, randomised, placebo-controlled, dose escalating study to assess the safety, tolerability, and pharmacokinetics of single and multiple doses of NVB302 administered orally to healthy volunteers
100 Clinical Results associated with Novacta Biosystems Ltd.
0 Patents (Medical) associated with Novacta Biosystems Ltd.
02 Jan 2007·Chembiochem : a European journal of chemical biologyQ4 · BIOLOGY
Chemical Biology: Directing Biosynthesis
Q4 · BIOLOGY
Article
Author: Appleyard, Antony N
100 Deals associated with Novacta Biosystems Ltd.
100 Translational Medicine associated with Novacta Biosystems Ltd.